Restless legs syndrome and diabetes overlap more often than either condition alone would predict. The combination drives sleep loss, daytime fatigue, and — through disrupted sleep — worse glycemic control. Diagnosis is clinical, with a small number of essential lab checks. Treatment starts with iron studies, lifestyle adjustments, and a careful look at any medications that may be aggravating symptoms; medications such as gabapentin enacarbil and selected dopamine agonists are added when needed.
How Common It Is in Diabetes
- General adult population prevalence of clinically significant RLS is about 5 to 10 percent
- In people with type 2 diabetes, estimates run 15 to 30 percent
- Higher in people with established peripheral neuropathy
- More common in women than men
- Risk rises with age, kidney disease, and pregnancy
- Iron deficiency, even without anemia, increases risk
Why RLS and Diabetes Overlap
- Peripheral neuropathy disrupts sensory signaling from the legs
- Iron transport and storage abnormalities affect brain dopamine pathways
- Chronic kidney disease — common in long-standing diabetes — increases RLS risk
- Medications used in diabetes care (some SSRIs, antiemetics) can worsen RLS
- Sleep apnea is common in diabetes and fragments sleep, amplifying RLS
- Disrupted sleep raises cortisol, worsens insulin resistance, and increases hunger
The Five IRLSSG Diagnostic Criteria
| Criterion | Description |
|---|---|
| 1 | Urge to move the legs, usually with uncomfortable sensations |
| 2 | Symptoms begin or worsen during periods of rest or inactivity |
| 3 | Symptoms partially or fully relieved by movement |
| 4 | Symptoms worse in the evening or night |
| 5 | Features 1 to 4 not solely accounted for by another condition |
Distinguishing RLS From Neuropathy
| Feature | RLS | Diabetic Peripheral Neuropathy |
|---|---|---|
| Sensation | Urge to move; creeping, crawling | Numbness, burning, tingling, electric |
| Timing | Evening, at rest | Often constant; worse at night but no rest trigger |
| Relief with movement | Yes | No |
| Distribution | Legs and sometimes arms | Stocking-glove pattern |
| Exam findings | Usually normal | Reduced monofilament, vibration, reflexes |
Evaluation Workup
- Complete symptom history including timing, triggers, and prior treatments
- Medication review for RLS-worsening drugs
- Iron studies — ferritin, transferrin saturation, total iron-binding capacity
- Complete blood count to assess for anemia
- Kidney function (creatinine, eGFR) and BUN
- Vitamin B12, magnesium, and folate if symptoms are atypical
- Thyroid function tests if other symptoms suggest thyroid disease
- Foot exam for peripheral neuropathy
- Screening for sleep apnea symptoms (snoring, witnessed apnea, daytime sleepiness)
- Polysomnography is not usually needed for RLS alone but is added when sleep apnea is suspected
Medications That Can Worsen RLS
- Some SSRIs and SNRIs (paroxetine, sertraline, venlafaxine)
- Tricyclic antidepressants
- Antipsychotics (haloperidol, risperidone)
- Antinausea drugs that block dopamine (metoclopramide, prochlorperazine)
- Sedating antihistamines (diphenhydramine)
- Some lithium and antiepileptic combinations
Lifestyle Steps
- Limit caffeine after noon
- Avoid alcohol within 4 hours of bedtime
- Keep consistent sleep and wake times
- Stretch calves and quads before bed
- Warm bath or shower in the evening
- Leg massage or pneumatic compression devices for some users
- Light to moderate daily aerobic activity
- Avoid heavy exercise within 3 to 4 hours of bedtime
- Hydrate adequately, especially with diuretic use
- Address coexisting sleep apnea, neuropathy, and pain
Medication Options
| Class | Examples | Notes |
|---|---|---|
| Iron replacement | Oral ferrous sulfate, IV iron | First-line if ferritin under 75 ng/mL |
| Alpha-2-delta ligands | Gabapentin enacarbil, pregabalin | Helpful for RLS with neuropathy or pain |
| Dopamine agonists | Pramipexole, ropinirole, rotigotine patch | Effective but risk of augmentation with long-term use |
| Low-dose opioids | Oxycodone, methadone | Reserved for severe, refractory cases |
| Benzodiazepines | Clonazepam | Limited role; risk of dependence and falls |
What Augmentation Means
Augmentation is a paradoxical worsening of RLS symptoms over months to years of dopamine agonist therapy. Symptoms appear earlier in the day, spread to the arms, or become more intense. Current guidelines suggest starting alpha-2-delta ligands first for many patients and reserving dopamine agonists for short-term or intermittent use, with careful monitoring.
How RLS Affects Diabetes Control
- Short sleep duration raises insulin resistance and fasting glucose
- Fragmented sleep elevates cortisol and inflammatory markers
- Daytime fatigue reduces physical activity
- Sleep loss increases appetite for high-carbohydrate foods
- Poor sleep worsens neuropathic pain
- Treating RLS often improves A1C indirectly by improving sleep quality
Related Reading
See our broader guides on prediabetes basics, treatment options, and our article on melatonin and diabetes.
The Bottom Line
Restless legs syndrome is common in diabetes, driven by peripheral neuropathy, iron deficiency, and the sleep disruption that comes with both conditions. Diagnosis follows five clinical criteria; iron studies and a medication review are essential first steps. Lifestyle adjustments, iron repletion when ferritin is low, and alpha-2-delta ligands work well for many patients. Dopamine agonists remain useful but require careful monitoring for augmentation. Because better sleep improves glycemic control, treating RLS is an under-recognized lever in overall diabetes care.
